Mylan Floats Options To Control Perrigo As A Subsidiary, Delist Its Shares
This article was originally published in The Tan Sheet
Executive Summary
Perrigo’s latest appeal for shareholders to reject a potential offer noted Mylan would delist Perrigo shares. Mylan says it “remains fully confident” more than 80% of Perrigo ordinary shares would vote to accept a takeover offer, but it is “fully committed and prepared to operate Perrigo as a controlled subsidiary.”
You may also be interested in...
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.
MLM Group Not Buying FTC Executive’s Concerns About Its Income Disclosure Guidance
FTC Division of Marketing Practices assistant director concerned direct selling self-regulation group’s guidance “will encourage deceptive conduct and facilitate deceptive earnings claims.” DSA president says the concerns might reflect the thinking of agency’s staff more than the intent of the agency’s regulations.
Some Topical Analgesics Draw Outside US FDA’s Lines For Formulations And Indications
FDA warns six businesses found selling directly to consumers topical formulations containing lidocaine outside the 0.5% to 4% concentration range allowed under OTC monographs for topical analgesics